Genmab’s Rina-S Advances in Endometrial Cancer Treatment with FDA Breakthrough Designation
Genmab A/S, a Danish biotech company, is poised for commercial success with its bispecific antibody Rina-S, which has shown impressive early-stage clinical results in advanced endometrial cancer and has received Breakthrough Therapy Designation from…
4 minutes to read